Dublin, Jan. 12, 2022 (GLOBE NEWSWIRE) — The "Global Smart Card in Healthcare Market By Product, By Component, By Regional Outlook, COVID-19 Impact Analysis Report and Forecast, 2021 – 2027" report has been added to ResearchAndMarkets.com's offering.
The global smart card in healthcare market size is expected to reach $2.3 billion by 2027, rising at a market growth of 13% CAGR during the forecast period. Smart cards in healthcare offer more privacy and security for managing personal data like personal health data and identity. In addition, this smart card validates a patient's identity at the time of medical care and helps in health system management.
The increasing adoption of smart cards in managing patient data with patient management is expected to boost the growth of smart cards in healthcare market. In addition, the surging usage of these smart cards decrease the chances of medical errors and reduce healthcare costs, which are estimated to surge the adoption of smart cards in the healthcare sector. Along with that, these smart cards have an embedded electronic chip with an integrated circuit, which decreases incidence regarding medical identities like fraud and theft. Due to these aspects, the smart card in healthcare market will witness a surge in demand. Growing demand for improved patient care with a low risk of fraud is expected to further augment the growth of the market.
The increasing cases of misuse of medical benefits and other frauds in the healthcare sector have significantly augmented in the past few years. Several national governments are inclining towards smart cards for obtaining medical records of people in the country. In addition, smart health cards are generally issued by healthcare insurance organizations for improved regulation of claims & other medical practices.
COVID-19 Impact Analysis
The outbreak of the global COVID-19 pandemic has impacted various segments of the business domain. The imposition of various restrictions across various nations like the travel ban, lockdowns, temporary ban on manufacturing units has negatively impacted many industrial verticals. In addition, the supply chain disruption and low demand for a wide range of products and services are among the key impacts of the pandemic. Smart health card companies have also faced a decline in sales due to the pandemic.
The adoption of smart health cards has witnessed a decline due to the frequent lockdowns and supply chain disruptions. In addition, the instability caused by the pandemic in the insurance and healthcare sector is negatively impacting the smart card in healthcare market. The less demand for these smart cards during the pandemic is expected to result in a slowdown of the overall market growth during the forecast period.
Market Growth Factors:
Increasing government initiatives
There are increasing government initiatives across various regions to push the implementation of smart cards in the healthcare sector to improve the functioning of the healthcare system. There are many organizations, which are also taking initiatives to promote the adoption of smart health cards among people. This is expected to augment the demand for smart cards in healthcare sector.
Growing digitalization in the healthcare industry
As everything is getting online and digitalization is at its high pace, healthcare companies are also getting updated with the trend and are introducing numerous products like smart health cards. In addition, the adoption of smart cards is increasing in order to manage patient data with patient management tools, which is anticipated to surge the demand for smart cards in healthcare market.
Market Restraining Factor:
Fair chances of data breaches
There are more chances of security and data breaches of these smart health cards. Though, several key players are highly investing in making these cards smarter and safer than before to provide assurance to the customers about the safety of their data. But, until the security system of smart health cards gets more advanced, people may restrict themselves from getting the smart health card to avoid any security and data breaches.
Product Outlook
Based on Product, the market is segmented into Contactless Smart Cards, Contact-based Smart Cards, Hybrid Smart Cards and Dual-interface Smart Cards. The hybrid smart cards segment is anticipated to witness the fastest growth rate over the forecast period. It is because these cards include more than one card technology. For example, these cards may consist of an embedded microprocessor smart card together with a contactless RFID proximity chip. In addition, dual interface smart cards utilize a single chip technology to connect through contact-based & contactless interfaces.
Component Outlook
Based on Component, the market is segmented into Microcontroller Based Smart Cards and Memory-card Based Smart Cards. The microcontroller-based smart cards segment acquired the highest share in the market in 2020. These cards are compact and have massive memory, which is expected to augment the growth of the segment over the forecast period. This segment is also projected to garner the fastest growth rate over the forecast period owing to the growing adoption in the healthcare sector.
Regional Outlook
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia Pacific region is estimated to procure the highest CAGR during the forecast period. It is due to aspects like the technologically improved healthcare system and supportive government initiatives, which are anticipated to surge the regional growth of the market during the forecast period.
Cardinal Matrix – Smart Card in Healthcare Market Competition Analysis
The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; American Express Company and Texas Instruments, Inc. are the forerunners in the Smart Card in Healthcare Market. Companies such as IDEMIA SAS, Giesecke & Devrient GmbH, Infineon Technologies AG are some of the key innovators in the market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Infineon Technologies AG, Texas Instruments, Inc., NXP Semiconductors N.V., Thales Group S.A., Atos Group, Giesecke & Devrient GmbH, American Express Company, VeriFone Holdings, Inc. (Francisco Partners), IDEMIA SAS (Advent International, Inc.) and CardLogix Corporation.
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 COVID-19 Impact
2.1.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis – Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2019, Jun – 2021, Aug) Leading Players
Chapter 4. Global Smart Card in Healthcare Market by Product
4.1 Global Contactless Smart Cards Market by Region
4.2 Global Contact-based Smart Cards Market by Region
4.3 Global Hybrid Smart Cards Market by Region
4.4 Global Dual-interface Smart Cards Market by Region
Chapter 5. Global Smart Card in Healthcare Market by Component
5.1 Global Microcontroller Based Smart Cards Market by Region
5.2 Global Memory-card Based Smart Cards Market by Region
Chapter 6. Global Smart Card in Healthcare Market by Region
Chapter 7. Europe Smart Card in Healthcare Market by Country
Chapter 8. Company Profiles
8.1 Infineon Technologies AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Texas Instruments, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 NXP Semiconductors N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Thales Group S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research and Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Atos Group
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 SWOT Analysis
8.6 Giesecke & Devrient GmbH
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.7 American Express Company
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Recent strategies and developments:
8.7.4.1 Partnerships, Collaborations, and Agreements:
8.8 VeriFone Holdings, Inc. (Francisco Partners)
8.8.1 Company Overview
8.9 IDEMIA SAS (Advent International, Inc.)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Acquisition and Mergers:
8.9.2.3 Product Launches and Product Expansions:
8.10. CardLogix Corporation
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
For more information about this report visit https://www.researchandmarkets.com/r/ivdxx3
Volkswagen Group posted its lowest sales figures in 10 years in 2021 at 8.9 million deliveries, the carmaker said on Wednesday, and it said it expected supply chain conditions to remain volatile in the first half of this year. The Volkswagen brand saw an 8.1% drop in sales to just under 4.9 million units, with the biggest fall in China at 14.8%, although battery-electric vehicle sales in the country quadrupled. "Under unusually challenging circumstances, Volkswagen reached a satisfying sales result," sales and marketing chief Klaus Zellmer said.
Thomas Koonce's life sentence in shooting of New Bedford man was commuted by Gov. Baker on Wednesday making him eligible for parole.
The Oracle of Omaha knows how to beat inflation. So ride his coattails.
Cathie Wood, the star fund manager and chief executive of ARK Invest, in a Tuesday monthly market update says that the used car market is where she is expecting possible losses after a surge in values.
Shares of Chinese electric-vehicle (EV) maker Nio (NYSE: NIO) were having a good day on Wednesday. As of 2:30 p.m. ET, Nio's American depositary shares were up about 5.1% from Tuesday's closing price, thanks to some upbeat news on pricing and a bullish note from Wall Street. The pricing news was simple and good: Nio's average transaction price in December was about $69,700, a strong number that was — according to the company's communications chief, Ma Lin — second only to Daimler's luxury stalwart, Mercedes-Benz.
In this article, we discuss the 5 stocks to consider in the latest portfolio of that Nancy Pelosi. If you want to skip our detailed analysis of these stocks, go directly to Nancy Pelosi Latest Portfolio: 2 Stocks to Watch. The stock trading activities of lawmakers on both sides of the aisle have come under […]
It's Wednesday morning, and Alibaba Group Holding (NYSE: BABA) stock is still going up. Do you remember what I said about Alibaba yesterday? Well, this morning, the chorus singing Alibaba's praises got even bigger.
The Wall Street giant really likes these dividend stocks — for very good reasons.
The start of a new year is always a convenient time to evaluate, or reevaluate, the stock portfolios. With a year’s worth of data behind us, and fresh forecasts ahead, investors can use the fresh start on the calendar to figure out if they need a rethink on their investment strategy. In a note from Morgan Stanley, chief investment officer Mike Wilson defines the key question for investors now as a simple binary decision, between staying with relative winners or going ‘bottom fishing.’ Each has i
These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q1 2022.
MarketWatch Picks has highlighted these products and services because we think readers will find them useful; the MarketWatch News staff is not involved in creating this content. Consumer prices rose 7% in December, as compared to the same month in 2020, according to data from the Labor Department released in January. Now, U.S. inflation is at a nearly 40-year-high.
Shares of electric car upstart Lucid (LCID) lit up on Tuesday, surging 9% in response to a what was actually a pretty even-keeled report by Charles Coldicott at UK research shop Redburn. Coldicott initiated coverage of Lucid Group with a "neutral" rating and a price target of only $39, but by the time trading was done for the day, Lucid stock had topped $45 a share. Why did investors have such an enthusiastic reaction to what was essentially a "hold" rating on the stock? Well, let's take a look.
If you’ve paid attention to politics in the past 10 years, you’ve likely heard a good deal of rhetoric about “the 1%” — those whose annual income puts them in the top 1% of earners. You’d be forgiven, though, for … Continue reading → The post What It Takes to Be in the 1% By State appeared first on SmartAsset Blog.
Tesla (TSLA) is a 'barometer' of market confidence, says TD Ameritrade chief market strategist JJ Kinahan. "This is a name that really is a confidence gauge in my opinion," Kinahan told Yahoo Finance Live.
The company has been giving away too much money
Digital currencies have great potential in a world that is increasingly going digital. Growth stocks can be volatile, too, but at least when the share price of a good business plummets, I can look at the company's revenue and profit potential to get an idea where the stock is going over the long term. For 2022, I've identified two beaten-down growth stocks that I'm ready to buy.
Tesla's (NASDAQ: TSLA) shareholders have endured some stomach-turning volatility in recent months. Tesla's shares have clawed back most of those losses in recent weeks. Goldman Sachs analyst Mark Delaney is bullish on Tesla's shares.
DoubleLine CEO Jeffrey Gundlach unveils his predictions for the year ahead. U.S. stocks are expensive and watch our for recession, he warns.
Commodities outperformed other asset classes in 2021, and with prices expected to increase further, Goldman Sachs reiterated their bullish call, saying that we’re at the start of a decade-long supercycle
In December, consumer prices rose 7% from a year prior. Here's how investing can help you deal with inflation.
